24
Participants
Start Date
June 30, 2008
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Revlimid
10mgs PO daily for 21 days of each 28 day cycle. Number of cycles: total of 24 or until subject relapses or unacceptable toxicity develops.
University Health Network, Princess Margaret Hospital, Toronto
Collaborators (1)
Celgene Corporation
INDUSTRY
University Health Network, Toronto
OTHER